Aids killed one person per minute last year, UN report says
UNAIDS pointed out that HIV programmes succeed when public health priorities prevail, as experiences in multiple countries attest.
Stay updated with breaking news from Oral Prep. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UNAIDS pointed out that HIV programmes succeed when public health priorities prevail, as experiences in multiple countries attest.
Study showed that having a range of options makes it more likely of there being one that will meet an individual’s needs and preferences and that it can and will be used.
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (Pfizer) and Shionogi Limited (Shionogi) as shareholders, today announced that the US Food and Drug Administration (FDA) approved Apretude, the first and only long-acting injectable pre-exposure prophylaxis (PrEP) option to reduce the risk of sexually acquired HIV-1.